Skip to main content
Log in

Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation

Bifokale versus unifokale rechtsatriale Stimulation unter plasmaspiegelkontrollierter Sotaloltherapie zur Prävention von Vorhofflimmern bei Patienten mit symptomatischer Sinusbradykardie und paroxysmalem Vorhofflimmern

  • ORIGINAL CONTRIBUTION
  • Published:
Herzschrittmachertherapie & Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

In vorangehenden Studien zur präventiven Therapie von Patienten mit paroxysmalem Vorhofflimmern (VHF) wurde bifokale rechtsatriale Stimulation (BS) bei gleichzeitiger antiarrhythmischer Therapie als effektive Strategie zur Verlängerung des rezidivfreien Intervalls beschrieben. Die vorliegende Studie vergleicht prospektiv die kumulative Prävalenz von VHF (AF Burden) während unifokaler (US) und bifokaler rechtsatrialer Stimulation unter spiegelkontrollierter Sotaloltherapie.

Methoden

Bei 19 Patienten mit symptomatischer Sinusknotendysfunktion und paroxysmalem Vorhofflimmern wurde ein DDDR-Schrittmachersystem mit einer rechtsatrial lateralen und einer tief septal am Koronarsinusostium platzierten Vorhofsonde implantiert. Eine anhand des Plasmaspiegels kontrollierte Sotaloltherapie wurde begonnen. Nach einer dreimonatigen Phase mit zurückhaltender rein antibradykarder Stimulation (Back-up-Phase) wurden die Patienten für 3 Monate auf kontinuierliche rechtsatrial BS oder US randomisiert. Im Anschluss wurde für weitere 3 Monate der komplementäre Modus programmiert. Primärer Studienendpunkt war AF Burden. Als sekundäre Endpunkte wurden die Anzahl von Episoden, das rezidivfreie Intervall und die Therapiesicherheit definiert.

Ergebnisse

Während der Back-up-Phase trat zu 12,4% der Zeit und während US und BS zu je 6,2% Vorhofflimmern auf. (p = 0,91 US vs. BS, p = 0,08 Back-up vs. US und p = 0,07 Back-up vs. BS, "Intention- to-treat"-Analyse.) Auch die „per-protocol“-Analyse ergab keinen Vorteil für eine der beiden Stimulationskonfigurationen. (US 4,8% und BS 5,4% VHF, p = 0,64). Atriale Stimulation verminderte tendenziell die Vorhofflimmerlast im Vergleich zur Back-up-Phase (US oder BS 6,2% vs. Back-up 8,8%, p = 0,09). Bei 3 Patienten kam es zur Dislokation der atrial septalen Sonde.

Schlussfolgerung

Atriale Stimulation unter Sotaloltherapie reduziert tendenziell die Vorhofflimmerlast bei Patienten mit Sinusknotendysfunktion und paroxysmalem VHF. Ein zusätzlicher präventiver Effekt von BS vs. US kann nicht bestätigt werden. Rechtsatrial BS ist möglicherweise mit einer höheren Sondendislokationsrate verbunden.

Abstract

Aims

Bifocal right atrial pacing (BP) has been reported to increase arrhythmia-free intervals in patients with paroxysmal atrial fibrillation (PAF) under antiarrhythmic drugs. This study compares AF burden with unifocal pacing (UP) vs BP under sotalol.

Methods

In 19 patients with PAF a DDDR pacemaker with right atrial lateral and CS ostial leads was implanted. Sotalol was initiated. After a 3 month back-up pacing period patients were randomized to continuous UP or BP for 3 months and crossed over for 3 more months. Primary endpoint was AF burden. Secondary endpoints included number of episodes, time to first recurrence and safety of BP.

Results

The intention to treat analysis revealed 12.4% AF during back-up, 6.2% during UP and BP (p = 0.91 UP vs BP, p = 0.08 back-up vs UP and p = 0.07 back-up vs BP). Per protocol analysis showed no advantage of either pacing mode (UP 4.8% and BP 5.4% AF, p=0.64). Overdrive pacing reduced AF burden to 6.2 vs 8.8% during back-up (p=0.09). Septal lead dislodgement occurred in 3 patients.

Conclusion

Atrial pacing tends to reduce AF burden in patients with PAF under sotalol. An incremental effect of BP vs UP cannot be confirmed. BP may be complicated by elevated lead dislodgement rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research 54:230–246

    Article  PubMed  CAS  Google Scholar 

  2. Arentz T, Ott P, von Rosenthal J et al (2003) Effect of atrial overdrive pacing on pulmonary vein focal discharge in patients with atrial fibrillation. Europace 5:25–31

    Article  PubMed  CAS  Google Scholar 

  3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952

    PubMed  CAS  Google Scholar 

  4. Daubert C, Gras D, Berder V, Leclercq C, Mabo P (1994) Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block. Arch Mal Coeur Vaiss 87 (Suppl):1535–1546

    PubMed  CAS  Google Scholar 

  5. Delfaut P, Saksena S, Prakash A, Krol RB (1998) Long-term outcome of patients with drug refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 32:1900–1908

    Article  PubMed  CAS  Google Scholar 

  6. Duytschaever M, Danse P, Eysbouts S, Allessie M (2002) Is there an optimal pacing site to prevent atrial fibrillation? an experimental study in the chronically instrumented goat. J Cardiovasc Electrophysiol 13:1264–1271

    Article  PubMed  Google Scholar 

  7. Friberg J, Buch P, Scharling H et al (2003) Rising rates of hospital admissions for atrial fibrillation. Epidemiology 14:666–672

    Article  PubMed  Google Scholar 

  8. Gregoratos G, Abrams J, Epstein AE et al (2002) ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106:2145–2161

    Article  PubMed  Google Scholar 

  9. Lau CP, Tse HF, Yu CM et al (2001) Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol 88:371–375

    Article  PubMed  CAS  Google Scholar 

  10. Levy T, Walker S, Rex S, Rochelle J, Paul V (2001) No incremental benefit of multisite atrial pacing compared with right atrial pacing in patients with drug refractory paroxysmal atrial fibrillation. Heart 85:48–52

    Article  PubMed  CAS  Google Scholar 

  11. Michelucci A, Padeletti L, Fradella GA et al (1984) Effects of atropine on atrial refractoriness and its dispersion in humans. Int J Clin Pharmacol Ther Toxicol 22:254–258

    PubMed  CAS  Google Scholar 

  12. Mirza I, James S, Holt P (2002) Biatrial pacing for paroxysmal atrial fibrillation a randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardiol 40:457–463

    Article  PubMed  Google Scholar 

  13. Misier AR, Opthof T, Van Hemel NM et al (1992) Increased dispersion of refractoriness in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol 19:1531–1535

    Article  PubMed  CAS  Google Scholar 

  14. Nielsen JC, Kristensen L, Andersen HR et al (2003) A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Coll Cardiol 42:614–623

    Article  PubMed  Google Scholar 

  15. Prakash A, Delfaut P, Krol RB et al (1998) Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol 82:1197–1204

    Article  PubMed  CAS  Google Scholar 

  16. Rha S-W, Kim Y-H, Hong MK et al (2007) Mechanisms responsible for the initiation and maintenance of atrial fibrillation assessed by non-contact mapping system. Int J Cardiol doi:10.1016/j.ijcard.2007.02.013

    Google Scholar 

  17. Saksena S, Prakash A, Hill M et al (1996) Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 28:687–694

    Article  PubMed  CAS  Google Scholar 

  18. Saksena S, Prakash A, Ziegler P et al; for the DAPPAF Investigators (2002) Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 40:1140–1150

    Article  PubMed  Google Scholar 

  19. Simpson RJ, Foster JR, Gettes LS (1982) Atrial excitability and conduction in patients with interatrial conduction defects. Am J Cardiol 50:1331–1337

    Article  PubMed  Google Scholar 

  20. Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937

    Article  PubMed  Google Scholar 

  21. Wattingney WA, Mensah GA, Croft JB (2003) Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 108:711–716

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Stockburger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stockburger, M., Gerhardt, L., Helms, S. et al. Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation. Herzschr. Elektrophys. 18, 250–258 (2007). https://doi.org/10.1007/s00399-007-0582-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-007-0582-9

Schlüsselwörter

Key words

Navigation